US9303033, G19, Table 33A, Compound 130

ID: ALA3916404

Chembl Id: CHEMBL3916404

PubChem CID: 137292514

Max Phase: Preclinical

Molecular Formula: C21H22N8O3

Molecular Weight: 434.46

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc([C@H](C)Nc2nc(NC3CC3)n3ncc(/C=C4\NC(=O)NC4=O)c3n2)cc1

Standard InChI:  InChI=1S/C21H22N8O3/c1-11(12-3-7-15(32-2)8-4-12)23-19-26-17-13(9-16-18(30)27-21(31)25-16)10-22-29(17)20(28-19)24-14-5-6-14/h3-4,7-11,14H,5-6H2,1-2H3,(H2,23,24,26,28)(H2,25,27,30,31)/b16-9-/t11-/m0/s1

Standard InChI Key:  JLPLVKRLRGSRQO-RCEBRVLHSA-N

Alternative Forms

  1. Parent:

    ALA3916404

    ---

Associated Targets(Human)

CSNK2B Tbio Casein kinase II alpha/beta (1504 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK2B Tbio Casein kinase II beta (977 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 434.46Molecular Weight (Monoisotopic): 434.1815AlogP: 2.06#Rotatable Bonds: 7
Polar Surface Area: 134.57Molecular Species: NEUTRALHBA: 9HBD: 4
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.24CX Basic pKa: 2.28CX LogP: 1.43CX LogD: 1.05
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.33Np Likeness Score: -1.02

References

1.  (2016)  Pyrazolopyrimidines and related heterocycles as CK2 inhibitors, 

Source

Source(1):